Skip to main content
HR 4242 118th Congress House Health Administrative law and regulatory procedures Alternative treatments Department of Health and Human Services Drug therapy Drug, alcohol, tobacco use Medical research

To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted…

Show full title

To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.

Introduced: June 21, 2023 Introduced by: Crenshaw, Dan Republican · Texas See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 23, 2023
Referred to the Subcommittee on Health.
Jun 21, 2023
Referred to the House Committee on Energy and Commerce.
Jun 21, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

This bill requires the Food and Drug Administration (FDA) to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy, including how to request support from the FDA for related investigational use exemptions.

What's happening now June 23, 2023

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 2
All 2 Democratic 1 Republican 1
D
Khanna, Ro
California · Jun 21, 2023
 R
Miller-Meeks, Mariannette
Iowa · Jun 21, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4242: To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.. 118th Congress. Open America. https://openamerica.io/bill/118-HR-4242/
MLA
"H.R. 4242: To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-4242/.
Bluebook (legal)
H.R. 4242, 118th Cong. (2026), https://openamerica.io/bill/118-HR-4242/.
Markdown link
[H.R. 4242: To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.](https://openamerica.io/bill/118-HR-4242/)
Report a problem